AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9388519 — intervention group
Group type: EXPERIMENTAL
Intervention: RT and daily low dose of CDDP (5 mg/m2)
Number of subjects: 24
Study 9388519 — intervention group
Group type: COMPARATOR
Intervention: RT only
Number of subjects: 24
Study 8198916 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopentone 5.1 mg kg‐1 with suxamethonium
Number of subjects: 43
Study 8198916 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 2.2 mg kg‐1 with suxamethonium
Number of subjects: 43
Study 2884854 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 96
Study 2884854 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 96
Study 29893222 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab 100 mg
Number of subjects: 149
Study 29893222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 28060585 — intervention group
Group type: EXPERIMENTAL
Intervention: Foreshadowed death narratives
Number of subjects: 635
Study 28060585 — intervention group
Group type: COMPARATOR
Intervention: Survivor narratives
Number of subjects: 635
Study 28060585 — intervention group
Group type: COMPARATOR
Intervention: Death narratives
Number of subjects: 635
Study 26677123 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrograde ventricle-sinus shunt (RVSS)
Number of subjects: 9
Study 26677123 — intervention group
Group type: COMPARATOR
Intervention: Ventricular-peritoneal shunt (VPS)
Number of subjects: 9
Study 23311877 — intervention group
Group type: EXPERIMENTAL
Intervention: OPTIMA-improved stoves
Number of subjects: 93
Study 23311877 — intervention group
Group type: COMPARATOR
Intervention: Control stoves
Number of subjects: 93
Study 22338818 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health action plan including child's current caries-risk status, identification of issues of concern, and one goal to improve on for the next visit.
Number of subjects: 69
Study 22338818 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified in the abstract).
Number of subjects: 69
Study 18804362 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 10 microg b.i.d. plus tiotropium 18 microg o.d.
Number of subjects: 847
Study 18804362 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 10 microg b.i.d.
Number of subjects: 847
Study 18804362 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg o.d.
Number of subjects: 847
Study 18804362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 847
Study 17122760 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted surgery (LPS)
Number of subjects: 610
Study 17122760 — intervention group
Group type: COMPARATOR
Intervention: Open surgery (LPT)
Number of subjects: 610
Study 12749510 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron alone (40 microg/kg i.v.)
Number of subjects: 120
Study 12749510 — intervention group
Group type: COMPARATOR
Intervention: Granisetron/dexamethasone combination (40 microg/kg granisetron + 8 mg dexamethasone)
Number of subjects: 120
Study 10833097 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubber Band Ligation (RBL)
Number of subjects: 133
Study 10833097 — intervention group
Group type: COMPARATOR
Intervention: Infra-red Coagulation (IRC)
Number of subjects: 133
Study 9170120 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg micronized progesterone administered in the evening
Number of subjects: 0
Study 9170120 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8466015 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 micrograms/mL norepinephrine
Number of subjects: 80
Study 8466015 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms/mL norepinephrine
Number of subjects: 80
Study 8466015 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 micrograms/mL norepinephrine
Number of subjects: 80
Study 8466015 — intervention group
Group type: COMPARATOR
Intervention: Plain tetracaine (0 micrograms/mL norepinephrine)
Number of subjects: 80
Study 31363043 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy favored by female physicians under ideal conditions
Number of subjects: 607
Study 31363043 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy favored by male physicians under ideal conditions
Number of subjects: 607
Study 31363043 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy favored by female physicians under current local resources
Number of subjects: 607
Study 31363043 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy favored by male physicians under current local resources
Number of subjects: 607
Study 31622158 — intervention group
Group type: EXPERIMENTAL
Intervention: β-alanine supplementation (6.4 g/day) during HIIT
Number of subjects: 18
Study 31622158 — intervention group
Group type: COMPARATOR
Intervention: Placebo (dextrose) during HIIT
Number of subjects: 18
Study 28923793 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 million allogeneic human mesenchymal stem cells
Number of subjects: 30
Study 28923793 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 million allogeneic human mesenchymal stem cells
Number of subjects: 30
Study 26162514 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet group
Number of subjects: 70
Study 26162514 — intervention group
Group type: COMPARATOR
Intervention: Non-tourniquet group
Number of subjects: 70
Study 25445808 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete program (Saluda)
Number of subjects: 480
Study 25445808 — intervention group
Group type: EXPERIMENTAL
Intervention: Program minus public commitment
Number of subjects: 480
Study 25445808 — intervention group
Group type: EXPERIMENTAL
Intervention: Program minus resistance to advertising
Number of subjects: 480
Study 25445808 — intervention group
Group type: EXPERIMENTAL
Intervention: Program minus leisure promotion
Number of subjects: 480
Study 25445808 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 480
Study 21946853 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischaemic anaesthesia with wrist and fingers held straight
Number of subjects: 0
Study 21946853 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischaemic anaesthesia with wrist and fingers flexed
Number of subjects: 0
Study 21946853 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischaemic anaesthesia
Number of subjects: 0
Study 18989245 — intervention group
Group type: EXPERIMENTAL
Intervention: h‐ANP (human atrial natriuretic peptide) treatment, 0.02 microg/kg/min for 5 days or more
Number of subjects: 18
Study 18989245 — intervention group
Group type: EXPERIMENTAL
Intervention: h‐ANP treatment
Number of subjects: 18
Study 18989245 — intervention group
Group type: COMPARATOR
Intervention: non‐h‐ANP treatment (Group N)
Number of subjects: 18
Study 16433401 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond
Number of subjects: 30
Study 16433401 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond NT/NRC
Number of subjects: 30
Study 16433401 — intervention group
Group type: EXPERIMENTAL
Intervention: One Up Bond F
Number of subjects: 30
Study 12577195 — intervention group
Group type: EXPERIMENTAL
Intervention: Trizivir (zidovudine, lamivudine, abacavir)
Number of subjects: 209
Study 12577195 — intervention group
Group type: COMPARATOR
Intervention: Continued HAART
Number of subjects: 209
Study 12577195 — intervention group
Group type: EXPERIMENTAL
Intervention: Trizivir
Number of subjects: 209
Study 10224212 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral sucrose (48% solution) before feeding
Number of subjects: 38
Study 10224212 — intervention group
Group type: COMPARATOR
Intervention: Intraoral water before feeding
Number of subjects: 38
Study 10224212 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral sucrose (48% solution) after feeding
Number of subjects: 38
Study 10224212 — intervention group
Group type: COMPARATOR
Intervention: Intraoral water after feeding
Number of subjects: 38
Study 10224212 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral sucrose (48% solution)
Number of subjects: 38
Study 10224212 — intervention group
Group type: COMPARATOR
Intervention: Intraoral water
Number of subjects: 38
Study 8914780 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrelin
Number of subjects: 0
Study 8914780 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study 1877037 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (200 micrograms twice daily) and terbutaline (500 micrograms four times daily)
Number of subjects: 27
Study 1877037 — intervention group
Group type: COMPARATOR
Intervention: Terbutaline alone (placebo)
Number of subjects: 27
Study 7088766 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg ergotamine by injection (6 i.v. and 11 i.m.)
Number of subjects: 41
Study 7088766 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg ergotamine by mouth
Number of subjects: 41
Study 7088766 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg ergotamine by suppository
Number of subjects: 41
Study 7088766 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma ergotamine levels exceeding 1.8 ng/ml
Number of subjects: 41
Study 31172717 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone
Number of subjects: 91
Study 31172717 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide inhalation suspension (BIS) via transnasal nebulization
Number of subjects: 91
Study 31172717 — intervention group
Group type: COMPARATOR
Intervention: Budesonide nasal spray (BNS)
Number of subjects: 91
Study 28295174 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotomy
Number of subjects: 245
Study 28295174 — intervention group
Group type: COMPARATOR
Intervention: Repeat PGE2
Number of subjects: 245
Study 26697823 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 meals a day (B2)
Number of subjects: 54
Study 26697823 — intervention group
Group type: COMPARATOR
Intervention: 6 meals a day (A6)
Number of subjects: 54
Study 24282036 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting Plasma Glucose (FPG)
Number of subjects: 486
Study 24282036 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-step 50 g Glucose Challenge Test (GCT)
Number of subjects: 486
Study 24282036 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 g Glucose Tolerance Test (GTT)
Number of subjects: 486
Study 22002075 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 24
Study 22002075 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 24
Study 18976320 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiepileptic drug (AED) monotherapy
Number of subjects: 0
Study 18976320 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (subgroup of AED monotherapy)
Number of subjects: 0
Study 17590500 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exercise (treadmill walking for 45 min at 50% of VO(2)peak)
Number of subjects: 9
Study 15200583 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular amphetamine use
Number of subjects: 214
Study 11679498 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant FSH
Number of subjects: 0
Study 11679498 — intervention group
Group type: COMPARATOR
Intervention: Urinary FSH
Number of subjects: 0
Study 10023367 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention on STD recognition, management, and prevention counselling
Number of subjects: 180
Study 10023367 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 180
Study 8167489 — intervention group
Group type: EXPERIMENTAL
Intervention: ABP machine
Number of subjects: 6
Study 8167489 — intervention group
Group type: EXPERIMENTAL
Intervention: TM2420 machine
Number of subjects: 6
Study 3071266 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin (3 x 600 mg in 100 ml 0.9% saline)
Number of subjects: 120
Study 3071266 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (3 x 500 mg in 100 ml 0.9% saline)
Number of subjects: 120
Study 3071266 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 x 100 ml of 0.9% saline)
Number of subjects: 120
Study 31658115 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh Frozen Plasma (FFP)
Number of subjects: 59
Study 31658115 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid (PlasmaLyte)
Number of subjects: 59
Study 30832678 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced feedback
Number of subjects: 2299
Study 30832678 — intervention group
Group type: COMPARATOR
Intervention: Standard feedback
Number of subjects: 2299
Study 27802112 — intervention group
Group type: EXPERIMENTAL
Intervention: Access2Aphasia™ (online-led assessment)
Number of subjects: 30
Study 27802112 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face (FTF) assessment
Number of subjects: 30
Study 26511799 — intervention group
Group type: EXPERIMENTAL
Intervention: Care as usual plus SOS training (N = 125)
Number of subjects: 250
Study 26511799 — intervention group
Group type: COMPARATOR
Intervention: Care as usual only (N = 125)
Number of subjects: 250
Study 23015618 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-controlled infusion of phenylephrine (100 µg ml(‐1))
Number of subjects: 222
Study 23015618 — intervention group
Group type: COMPARATOR
Intervention: Manual-controlled infusion of phenylephrine
Number of subjects: 222
Study 23015618 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-controlled infusion of phenylephrine
Number of subjects: 222
Study 21518565 — intervention group
Group type: EXPERIMENTAL
Intervention: Coated VICRYL Plus antibacterial (Polyglactin 910) suture
Number of subjects: 101
Study 21518565 — intervention group
Group type: COMPARATOR
Intervention: Chinese silk suture
Number of subjects: 101
Study 19328368 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunmed GEB
Number of subjects: 34
Study 19328368 — intervention group
Group type: COMPARATOR
Intervention: Portex GEB
Number of subjects: 34
Study 19328368 — intervention group
Group type: EXPERIMENTAL
Intervention: Greenfield GEB
Number of subjects: 34
Study 19328368 — intervention group
Group type: EXPERIMENTAL
Intervention: Eschmann GEB
Number of subjects: 34
Study 19328368 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 34
Study 19328368 — intervention group
Group type: EXPERIMENTAL
Intervention: EM physicians
Number of subjects: 34
Study 19328368 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthesiologists
Number of subjects: 34
Study 17018329 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNTA (7.5 U, 25 U, or 50 U)
Number of subjects: 418
Study 17018329 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNTA (25 U or 50 U)
Number of subjects: 418
Study 17018329 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of BoNTA (25 U or 50 U)
Number of subjects: 418
Study 17018329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 418
Study 12833013 — intervention group
Group type: COMPARATOR
Intervention: Clobetasol propionate 0.05% foam plus vehicle spray
Number of subjects: 25
Study 12833013 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.05% foam plus 0.25% zinc pyrithione spray
Number of subjects: 25
Study 10827212 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g/d FOS
Number of subjects: 10
Study 10827212 — intervention group
Group type: COMPARATOR
Intervention: Sucrose
Number of subjects: 10
Study 8895624 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous passive motion machine
Number of subjects: 83
Study 8895624 — intervention group
Group type: COMPARATOR
Intervention: Drop and dangle protocol
Number of subjects: 83
Study 1520648 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg bid)
Number of subjects: 0
Study 1520648 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (20-40 mg bid)
Number of subjects: 0
Study 1520648 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Atenolol and Nifedipine
Number of subjects: 0
Study 6238190 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophyllan (SPG)
Number of subjects: 326
Study 6238190 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 326
Study 30773564 — intervention group
Group type: EXPERIMENTAL
Intervention: Interscalene brachial plexus block (group I) with 0.2% ropivacaine 10 mL
Number of subjects: 40
Study 30773564 — intervention group
Group type: COMPARATOR
Intervention: C5‐6 nerve root block (group C) with 0.2% ropivacaine 10 mL
Number of subjects: 40
Study 30391368 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG classification at 24 hours
Number of subjects: 164
Study 30391368 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG classification at 48 hours
Number of subjects: 164
Study 30391368 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG reactivity at 24 hours
Number of subjects: 164
Study 28583834 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured education intervention in two sessions
Number of subjects: 60
Study 28583834 — intervention group
Group type: COMPARATOR
Intervention: Control group without intervention
Number of subjects: 60
Study 25479729 — intervention group
Group type: EXPERIMENTAL
Intervention: Training Group (TG) - supervised bilateral short contact hopping training
Number of subjects: 20
Study 25479729 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - no intervention
Number of subjects: 20
Study 23706715 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 Amb a 1 units ragweed AIT
Number of subjects: 565
Study 23706715 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 Amb a 1 units ragweed AIT
Number of subjects: 565
Study 23706715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 565
Study 21211840 — intervention group
Group type: EXPERIMENTAL
Intervention: Early peripheral retinal ablation
Number of subjects: 63
Study 21211840 — intervention group
Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 63
Study 21211840 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 63
Study 19372331 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 1 mg/kg followed by an infusion of 2.5 mg x kg(‐1) x h(‐1) for 59 min
Number of subjects: 8
Study 19372331 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (C(blood): 225 ng/mL)
Number of subjects: 8
Study 19372331 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean arterial blood pressure inclusion
Number of subjects: 8
Study 16894336 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg)
Number of subjects: 40
Study 16894336 — intervention group
Group type: COMPARATOR
Intervention: Low-dose EPT (1 mg 17beta-estradiol + 0.5 mg norethisterone acetate)
Number of subjects: 40
Study 16894336 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (T and low-dose EPT)
Number of subjects: 40
Study 15136349 — intervention group
Group type: COMPARATOR
Intervention: Triple-contrast CT scan
Number of subjects: 91
Study 15136349 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal-contrast CT scan
Number of subjects: 91
Study 11280073 — intervention group
Group type: EXPERIMENTAL
Intervention: Polonga TAb (1 g)
Number of subjects: 43
Study 11280073 — intervention group
Group type: COMPARATOR
Intervention: Haffkine antivenom (10 g)
Number of subjects: 43
Study 9512850 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA) removal when deeply anaesthetised
Number of subjects: 165
Study 9512850 — intervention group
Group type: COMPARATOR
Intervention: Laryngeal Mask Airway (LMA) removal when awake
Number of subjects: 165
Study 7817029 — intervention group
Group type: EXPERIMENTAL
Intervention: External argon laser choroidotomy
Number of subjects: 175
Study 7817029 — intervention group
Group type: COMPARATOR
Intervention: Needle drainage
Number of subjects: 175
Study 3377955 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative intercostal nerve blocks of the 6th to 12th nerves bilaterally using 0.5% bupivacaine with adrenaline 250 micrograms
Number of subjects: 20
Study 3377955 — intervention group
Group type: COMPARATOR
Intervention: Control group with adrenaline infiltrated into the intercostal space
Number of subjects: 20
Study 29617982 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg single oral dose of gepotidacin
Number of subjects: 69
Study 29617982 — intervention group
Group type: EXPERIMENTAL
Intervention: 3000 mg single oral dose of gepotidacin
Number of subjects: 69
Study 29617982 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined dose groups (1500 mg and 3000 mg)
Number of subjects: 69
Study 29617982 — intervention group
Group type: COMPARATOR
Intervention: N/A (control not specified)
Number of subjects: 69
Study 26020712 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine 15-20 mg
Number of subjects: 1075
Study 24228504 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum drainage at -20 kPa
Number of subjects: 21
Study 24228504 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum drainage at -40 kPa
Number of subjects: 21
Study 24228504 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum drainage at -60 kPa
Number of subjects: 21
Study 21464374 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body hypothermia to 33.5°C for 72 hours
Number of subjects: 221
Study 21464374 — intervention group
Group type: COMPARATOR
Intervention: Standard care (37°C)
Number of subjects: 221
Study 18026685 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% oxygen
Number of subjects: 100
Study 18026685 — intervention group
Group type: COMPARATOR
Intervention: 30% oxygen
Number of subjects: 100
Study 16848340 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse case management and incentives (NCMI)
Number of subjects: 520
Study 16848340 — intervention group
Group type: COMPARATOR
Intervention: Standard care and incentives (Control)
Number of subjects: 520
Study 16848340 — intervention group
Group type: EXPERIMENTAL
Intervention: Both programs
Number of subjects: 520
Study 12764691 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental 5‐7 mg/kg IV
Number of subjects: 30
Study 12764691 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate 0.2‐0.3 mg/kg IV
Number of subjects: 30
Study 10838679 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Eclectic Psychotherapy (BEP)
Number of subjects: 42
Study 10838679 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 42
Study 9112508 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable stent
Number of subjects: 116
Study 9112508 — intervention group
Group type: COMPARATOR
Intervention: No stent
Number of subjects: 116